EpiVax
AcquiredHome - EpiVax: Immunogenicity Experts
United States · $1.2M raised
- Website
- epivax.com
- Total Funding
- $1.2M
- Last Round
- $1.2M BridgeJun 2018
- Rounds
- 1
- Acquisition Date
- Apr 2026
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Vaccine development
Summary
EpiVax is a Biotech company based in United States. It has raised $1.2M in total across 1 round, most recently a $1.2M Bridge round in Jun 2018. Investors include SV Health Investors and Morningside Venture Investments.
Tech & App Stack
6 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Apr 2026
Sign up to see all 2 events
Funding: Bridge. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/epivax"><img src="https://indexed.vc/api/badge/company/epivax" alt="EpiVax on Indexed.vc" width="260" height="76" /></a>